ArticleBMC microbiology2025
The efficacy of nanoparticles on soil microbial biodiversity and the prevention of Fusarium wilt disease (Fusarium oxysporum f.sp. lycopersici).
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Microalgae-Mediated Nanotechnology for Sustainable Agriculture: Applications, Advances, and Future Prospects.International journal of molecular sciences · 2026Review
- Comparative efficacy of conventional and nano-formulations of silica and chitosan against Fusarium oxysporum causing wilt in pea (Pisum sativum).BMC plant biology · 2026Article
- Applications of nanoparticles in plant disease identification and control for sustainable crop production.Discover nano · 2026Review
- Soil-borne diseases in medicinal plants: linking allelopathy and host immunity to microbiome-based interventions.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium oxysporum f.sp. lycopersici (FOL) wilt endangers Egyptian tomato productivity. Nanotechnology has emerged as an efficient tool for managing plant diseases. This study evaluated salicylic acid nanoparticles (SA-NPs) and glycyrrhizic acid ammonium salt nanoparticles (GAS-NPs) against F. oxysporum in vitro. SA-NPs reduced F. oxysporum growth by 37.8%, and GAS-NPs by 18.9% at 3 ml/L, while SA-NPs at high doses significantly reduced the bacterial count in the tomato rhizosphere. Under greenhouse conditions, high doses of SA-NPs suppressed disease by 73%, compared to 87-93% for other treatments, coinciding with a significant decrease in the overall bacterial count in the tomato rhizosphere. A high dose of SA-NPs reduced heterotrophic, copiotrophic, and fluorescent pseudomonads in the tomato rhizosphere but did not affect the total number of fungi. In vitro, a high dose of both nanoparticles did not significantly reduce bacterial growth in four tested strains: Leclercia adecarboxylata, Pseudomonas putida, Enterobacter ludwigii, and Bacillus marcorestinctum. This suggests that while SA-NP doesn't directly affect bacterial growth, it may interact with tomato roots, indirectly affecting the rhizosphere bacterial population. All treatments increased the expression of ethylene-responsive transcription factor 3 (RAP), xyloglucan endotransglucosylase 2 (XET-2), catalytic hydrolase-2 (ACS-2), phenylalanine ammonia-lyase 5 (PAL5), lipoxygenase D (LOXD), proteinase inhibitor II (PINII), and pathogenesis-related protein 1 (PR1). The highest gene expression levels were obtained from 1 ml/L GAS-NPs and SA-NPs field applications. Furthermore, SA-NPs at 1 ml/L were the most efficient in controlling tomato Fusarium wilt, followed by GAS-NPs. This study investigates the possibility of nanotechnology-based techniques for decreasing Fusarium wilt in tomatoes. However, because of the deleterious impact on the soil bacterial community, high dosages of NPs, particularly SA-NPs, should be applied with caution. Future research should focus on optimizing NPs doses to maintain a balance between efficient disease control and the maintenance of the beneficial complexity of soil microbial biodiversity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.